References
- Wang F, Luo L-D, Pan J-H, Huang L-H, Lv H-W, Guo Q, et al. Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori. World J Gastroenterol 2012;18:7212.
- Sughra K, Birbach A, de Martin R, Schmid JA. Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling. PLoS One 2010;5:e12683.
- McPherson AJ, Snell LM, Mak TW, Watts TH. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J Biol Chem 2012;287:23010–19.
- Li J, Shen L, Lu F-R, Qin Y, Chen R, Li J, et al. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacol Sin 2012;33:242–9.
- Kwon O-H, Park S-J, Kang T-W, Kim M, Kim J-H, Noh S-M, et al. Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome. Cancer Lett 2012;314:73–81.
- Carattoli A, Pezzella C, Pietroiusti A, Galante A, Pezzotti P, Luzzi I. Cytotoxin-associated gene A and vacuolating cytotoxin A in human isolates of Helicobacter pylori and their association with the clinical status of ulcer disease. Eur J Gastroenterol Hepatol 2000;12:1207–13.
- Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999;37:2274–9.
- Galvis AA, Trespalacios-Rangel A, Otero W, Mercado-Reyes M, Poutou-Piñales R. Prevalence of cagA, vacA, babA2 and iceA genes in H. pylori strains isolated from Colombian patients with functional dyspepsia. Pol J Microbiol 2012;61:33–40.
- Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010;23:713–39.
- Wang C, Deng X, Cao Y. Expression of tumor necrosis factor receptor associated factor 1 in nasopharyngeal carcinoma and paracancerous tissues. Chin J Cancer 2000;19:857–9.
- Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001;20:6482–91.
- Hahm KB, Song YJ, Oh TY, Lee JS, Surh Y-J, Kim YB, et al. Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J Biochem Mol Biol 2003;36:82–94.
- Hahm K-B, Lim H-Y, Sohn S, Kwon H-J, Lee K-M, Lee J-S, et al. In vitro evidence of the role of COX-2 in attenuating gastric inflammation and promoting gastric carcinogenesis. J Environ Pathol Toxicol Oncol 2002;21:165–76.
- Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, et al. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001;15:647–57.
- Arron JR, Pewzner-Jung Y, Walsh MC, Kobayashi T, Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor–associated factor (TRAF) 2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 2002;196:923–34.
- Yu M. Anti-apoptotic biological function and mechanism of TRAF1 induced aggregation of mitochondria. Wu Han: Huazhong University of Science and Technology; 2009.
- Raszeja-Wyszomirska J, Wunsch E, Kempinska-Podhorodecka A, Smyk DS, Bogdanos DP, Milkiewicz M, et al. TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis. Clin Dev Immunol 2013;2013:1–7.
- Kempinska-Podhorodecka A, Shums Z, Wasilewicz M, Wunsch E, Milkiewicz M, Bogdanos DP, et al. TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2012;2012:1–7.